Amicus Therapeutics
FOLD
#3311
Rank
S$5.82 B
Marketcap
S$18.55
Share price
0.00%
Change (1 day)
90.59%
Change (1 year)

EPS for Amicus Therapeutics (FOLD)

EPS in 2023 (TTM): S-$0.87

According to Amicus Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$0.14. In 2022 the company made an earnings per share (EPS) of S-$1.05 an increase over its 2021 EPS that were of S-$1.18.

EPS history for Amicus Therapeutics from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$0.87-17.21%
2022S-$1.05-10.87%
2021S-$1.18-14.02%
2020S-$1.37-29.14%
2019S-$1.93-18.82%
2018S-$2.381.64%
2017S-$2.3422%
2016S-$1.9226.05%
2015S-$1.5227.96%
2014S-$1.19-19.13%
2013S-$1.475.5%
2012S-$1.40-15.5%
2011S-$1.65-35.18%
2010S-$2.55610.71%
2009S-$0.36-83.91%
2008S-$2.23-86.15%
2007S-$16.09-85.97%
2006S-$114.7082.72%
2005S-$62.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
S$5.22-3,806.93%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
S$3.02-2,245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$3.68-2,715.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
S-$0.19 36.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S-$0.02561-81.82%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.49-445.45%๐Ÿ‡บ๐Ÿ‡ธ USA